Moteur de recherche d’entreprises européennes
Financement de l’UE (4 033 858 €) : Biofilms de Breaking Bad. Des règles d’analyse et de conception innovantes pour les interfaces antifouling de nouvelle génération Hor13/11/2018 Programme de recherche et d'innovation de l'UE « Horizon »
Texte
Biofilms de Breaking Bad. Des règles d’analyse et de conception innovantes pour les interfaces antifouling de nouvelle génération
Biofilms, i.e. communities of micro-organisms that attach and grow on a solid surface, cause about 80% of infections in humans and disinfectants rarely succeed in destroying them. They cost European economy billions of euro annually. The BREAK BIOFILMS Training Network aims to solve this issue by training the next generation leaders. They will understand the (bio)physicochemical mechanisms of biofilm formation, be able to produce technology for detecting and identifying biofilm formation with extreme sensitivity, and develop next generation biocides for preventing and destroying biofilms in industrial and biomedical areas. This integrated strategy from biofilm detection to destruction that builds on key innovations from the partner labs, is globally distinctive and promises significant progress. The network brings together world leaders in sensors, cell imaging, microbiology, interfacial engineering and nanoformulation from 6 universities, 9 companies, a research centre, and a Business and Innovation Centre. Thus, it is ideal to provide technical, industrial and business training to 15 ESRs and support the missions of the industry partners who will provide deep insights into the most pressing and impactful challenges. The graduates will be ideally placed to enter and support existing European industry across a number of different sectors (biomedical, food, antimicrobials). However, they will also be capable of creating new businesses thanks to a combination of in depth training in entrepreneurship and direct experience of establishing and running a virtual company as part of the training network. Beyond the trained researchers, this project will produce technologies that will enhance the productivity of European industry, create intellectual property with a strong probability of commercialization and improve the health and well-being of European citizens by minimizing infection rates and the inappropriate use of ineffective biocides that is leading to resistance.
| Abbott Ireland | ? |
| Aarhus Universitet | 595 044 € |
| Agencia Estatal Consejo Superior de Investigaciones Cientificas | 501 810 € |
| Asociacion de Investigacion de Industrias Carnicas del Principado de Asturias | 250 905 € |
| Dublin City University | 549 369 € |
| Universidad de Oviedo | 501 810 € |
| Universita Degli Studi Di Bari Aldo Moro | 522 999 € |
| Universitaet ULM | 505 577 € |
| University of Warwick | 606 345 € |
https://cordis.europa.eu/project/id/813439
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Abbott Ireland, Cootehill, Irlande.